Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study)

被引：0
|
作者：
Naohiro Okano
Chigusa Morizane
Shogo Nomura
Hideaki Takahashi
Hidetaka Tsumura
Hironaga Satake
Nobumasa Mizuno
Kunihiro Tsuji
Kazuhiko Shioji
Akinori Asagi
Kohichiroh Yasui
Sho Kitagawa
Tomomi Kashiwada
Atsushi Ishiguro
Masashi Kanai
Makoto Ueno
Takashi Ogura
Satoshi Shimizu
Kazutoshi Tobimatsu
Masayo Motoya
Koji Nakashima
Masafumi Ikeda
Takuji Okusaka
Junji Furuse
机构：
[1] Kyorin University Faculty of Medicine,Department of Medical Oncology
[2] National Cancer Center Hospital,Department of Hepatobiliary and Pancreatic Oncology
[3] National Cancer Center,Biostatistics Division, Center for Research Administration and Support
[4] National Cancer Center Hospital East,Department of Hepatobiliary and Pancreatic Oncology
[5] Hyogo Cancer Center,Department of Gastroenterology
[6] Kobe City Medical Center General Hospital,Department of Medical Oncology
[7] Aichi Cancer Center Hospital,Department of Gastroenterology
[8] Ishikawa Prefectural Central Hospital,Department of Gastroenterology
[9] Niigata Cancer Center Hospital,Department of Internal Medicine
[10] National Hospital Organization Shikoku Cancer Center,Department of Gastrointestinal Medical Oncology
[11] Kyoto Prefectural University of Medicine,Department of Gastroenterology and Hepatology
[12] Sapporo Kosei General Hospital,Department of Gastroenterology
[13] Saga University,Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine
[14] Teine Keijinkai Hospital,Department of Medical Oncology
[15] Kyoto University,Department of Medical Oncology, Graduate School of Medicine
[16] Kanagawa Cancer Center,Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division
[17] St. Marianna University School of Medicine,Department of Clinical Oncology
[18] Saitama Cancer Center,Department of Gastroenterology
[19] Kobe University Graduate School of Medicine,Division of Gastroenterology, Department of Internal Medicine
[20] Sapporo Medical University School of Medicine,Department of Gastroenterology and Hepatology
[21] University of Miyazaki Hospital,Department of Clinical Oncology
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Pancreatic cancer; Gemcitabine; Oxaliplatin; Platinum compounds;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1835 / 1843
页数：8
相关论文
共 50 条
  • [41] Voice of cancer patients: Association of family history with genetic mutations in breast and ovarian cancer
    Aggarwal, Sangeeta
    Sharma, Rahul
    Sharma, Rishi
    Aggarwal, Alok
    CANCER RESEARCH, 2018, 78 (04)
  • [42] THE INFLUENCE OF FAMILY HISTORY OF BREAST AND PROSTATE CANCER ON PROSTATE CANCER DIAGNOSES IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDY
    Castro, R.
    Tammela, T.
    Andriole, G.
    Teloken, C.
    Rittmaster, R.
    Wilson, T.
    Fowler, I.
    Fueyo, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 279 - 279
  • [43] Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in 1st line metastatic pancreatic cancer - a multicenter phase II study
    Kullmann, F.
    Hollerbach, S.
    Fuchs, M.
    Messmann, H.
    Dollinger, M. M.
    Trojan, J.
    Harder, J.
    Gaebele, E.
    Hinke, A.
    Endlicher, E.
    EJC SUPPLEMENTS, 2007, 5 (04): : 269 - 269
  • [44] A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study
    Ma, CX
    Steen, P
    Rowland, KM
    Niedringhaus, RD
    Fitch, TR
    Kugler, JW
    Hillman, DW
    Perez, EA
    Ingle, JN
    Adjei, AA
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 226 - 231
  • [45] Serum selenium and pancreatic cancer: a prospective study in the Prostate, Lung, Colorectal and Ovarian Cancer Trial cohort
    Sharmila Chatterjee
    Gerald F. Combs
    Amit Chattopadhyay
    Rachael Stolzenberg-Solomon
    Cancer Causes & Control, 2019, 30 : 457 - 464
  • [46] Serum selenium and pancreatic cancer: a prospective study in the Prostate, Lung, Colorectal and Ovarian Cancer Trial cohort
    Chatterjee, Sharmila
    Combs, Gerald F., Jr.
    Chattopadhyay, Amit
    Stolzenberg-Solomon, Rachael
    CANCER CAUSES & CONTROL, 2019, 30 (05) : 457 - 464
  • [47] BRCA1 screening in patients with a family history of breast or ovarian cancer
    Arver, B
    Claro, A
    Langerod, A
    Borresen-Dale, AL
    Lindblom, A
    GENETIC TESTING, 1999, 3 (02): : 223 - 226
  • [48] Referral of patients with a family history of breast/ovarian cancer - GPs' knowledge and expectations
    Rose, PW
    Watson, E
    Yudkin, P
    Emery, J
    Murphy, M
    Fuller, A
    Lucassen, A
    FAMILY PRACTICE, 2001, 18 (05) : 487 - 490
  • [49] Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: A multicenter phase II study
    Kakolyris
    ONCOLOGY, 2006, 71 (3-4) : 203 - 203
  • [50] Phase II trial of gemcitabine plus carboplatin (plus trastuzumab in HER2+patients) in metastatic breast cancer patients
    Loesch, DM
    Asmar, L
    McIntyre, KJ
    Doane, LL
    McKittrick, RJ
    Monticelli, MA
    Paul, D
    Vukelja, SJ
    Zhan, F
    Boehm, KA
    O'Shaughnessy, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S280 - S281
12345